Godavari Drugs Ltd

Capital Actions

• Approved working capital limits up to Rs 340 million from ICICI Bank per Credit Letter 12 Oct 2026.
• Authorization to MD Mukund Kakani (DIN: 00104646) to accept, negotiate, finalize, and execute the facility and security documents.
• Security creation for the facility as per bank requirements is authorized.
• Facilities within borrowing limits approved by members under Section 180(1)(c) via 16 May 2022 special resolution.

AGM details

• AGM held on 25 September 2026 at 03:00 PM IST via VC/OAVM.
• Record date: 18 September 2026; total shareholders on record: 7,300.
• Attendance: Promoter group 9, public 77 via video conference.
• Four resolutions were put to vote and all were approved.

Resolutions

• Resolution 1 (Ordinary): Adopt audited financial statements and reports for year ended 31 March 2026.
• Resolution 2 (Ordinary): Re-appoint Ghanshyam Jaju as Director by rotation.
• Resolution 3 (Ordinary): Ratify remuneration of Cost Auditors for year ending 31 March 2027.
• Resolution 4 (Special): Alter Main Objects Clause to include new manufacturing and nutraceutical activities.

Voting results

• Resolution 1: Passed; 99.96% in favour, 0.04% against.
• Resolution 2: Passed; 99.96% in favour, 0.04% against.
• Resolution 3: Passed; 99.96% in favour, 0.04% against.
• Resolution 4: Passed; 99.96% in favour, 0.04% against.

Dividend

• No dividend proposed or declared.

Directors

• Re-appointment by rotation of Mr. Ghanshyam Jaju as Director.

Auditors

• Remuneration of Cost Auditors ratified for the financial year ending 31 March 2027.

Material related party transactions

• No material related party transactions disclosed or approved.

Other approvals

• Approval of alteration to Main Objects Clause as described.

AGM Details

• Date/time: 25 September 2026, 3:00 PM IST, through VC/OAVM.
• Mode: VC/OAVM; deemed venue: registered office.
• Remote e-voting: 22–24 September 2026; cut-off date: 18 September 2026.
• Attendance: 86 members; proxies not applicable; all directors attended via VC.
• Conclusion: meeting concluded at 4:22 PM.

Key Resolutions

• Adoption of standalone financial statements for year ended March 31, 2026.
• Re-appointment of Ghanshyam Jaju by rotation as director.
• Remuneration ratified for cost auditors: ₹40,000 for FY 2027.
• Alter MOA: add main object for nutraceuticals, dietary supplements, and related products.

Voting status

• Consolidated voting results to be submitted to the Stock Exchange and posted within two working days.

Godavari Drugs Limited: Trading window closed from 01 October 2026 till 48 hours after declaration of unaudited half-year results for the period ended 30 September 2026.

AGM notice accessibility and key dates

• Notice of 38th AGM on Sep 25, 2026 at 3:00 PM via VC/OAVM.
• Notice accessible on company website and BSE; emails not registered with RTA.
• Cut-off date for eligibility: Sep 18, 2026.
• Electronic voting window: Sep 22, 2026 09:00 AM to Sep 24, 2026 05:00 PM.
• Shareholders should update email addresses to receive notices electronically.

Key Decisions

• Board approved insertion of Main Object No. 4 in MOA for nutraceuticals, subject to member approval.
• Revised notice issued for 38th AGM on 25 September 2026 at 3:00 PM via VC/OAVM.
• Amendment to take effect upon Members' approval at AGM and filing of Form MGT-14.

Board approval and filing status

• Board approved the deviation/variation in utilisation of funds.
• Statement filed with the Stock Exchange.